The development of new medications in the US is a lengthy process governed by the FDA. The drug development process involves coordination between drug sponsors, clinical researchers, and regulatory authorities. All drugs must move through the pipeline of discovery, investigation, clinical trials, and FDA approval before being marketed to consumers. This activity reviews the federal regulations of medication development and highlights the interplay between the FDA, drug manufacturers, and clinical researchers.

**Objectives:**
- Outline specific laws about regulations of drug development by the FDA.
- Describe the New Drug Application process, including expedited review programs.
- Summarize the intellectual property laws regulating drug development.
- Explain the process of regulating the production of generic small-molecule drugs and biologics.